بدائل البحث:
largest decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث)
less decrease » mean decrease (توسيع البحث), we decrease (توسيع البحث), levels decreased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
يعرض 1,081 - 1,100 نتائج من 1,542 نتيجة بحث عن 'significantly ((((((less decrease) OR (largest decrease))) OR (nn decrease))) OR (teer decrease))', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 1081
    Typical structure of a centrifugal nozzle [25].

    Typical structure of a centrifugal nozzle [25]. حسب Yanyu Cui (19173181)

    منشور في 2025
    "…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …"
    أضف إلى المفضلة
    محفوظ في:
  2. 1082
    Cross-sectional velocity distribution contour.

    Cross-sectional velocity distribution contour. حسب Yanyu Cui (19173181)

    منشور في 2025
    "…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …"
    أضف إلى المفضلة
    محفوظ في:
  3. 1083
    Mesh generation details.

    Mesh generation details. حسب Yanyu Cui (19173181)

    منشور في 2025
    "…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …"
    أضف إلى المفضلة
    محفوظ في:
  4. 1084
    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.pdf

    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  5. 1085
    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  6. 1086
    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  7. 1087
    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  8. 1088
    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  9. 1089
    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

    منشور في 2024
    "…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"
    أضف إلى المفضلة
    محفوظ في:
  10. 1090
    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  11. 1091
    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx

    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  12. 1092
    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  13. 1093
    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  14. 1094
    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  15. 1095
    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  16. 1096
    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  17. 1097
    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  18. 1098
    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  19. 1099
    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:
  20. 1100
    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg حسب Xiaqin Zhang (10211396)

    منشور في 2025
    "…Richness was significantly decreased from pre-treat to post-treat.…"
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: